Mind Medicine (MindMed) (MNMD) Competitors $7.22 -0.26 (-3.48%) (As of 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends MNMD vs. TLRY, CRON, USNA, CDXC, BTMD, CGC, ACB, MDWD, FTLF, and SNYRShould you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), ChromaDex (CDXC), biote (BTMD), Canopy Growth (CGC), Aurora Cannabis (ACB), MediWound (MDWD), FitLife Brands (FTLF), and Synergy CHC Corp. (Uplisting) (SNYR). These companies are all part of the "medicinals & botanicals" industry. Mind Medicine (MindMed) vs. Tilray Cronos Group USANA Health Sciences ChromaDex biote Canopy Growth Aurora Cannabis MediWound FitLife Brands Synergy CHC Corp. (Uplisting) Tilray (NASDAQ:TLRY) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Which has stronger earnings and valuation, TLRY or MNMD? Mind Medicine (MindMed) has lower revenue, but higher earnings than Tilray. Tilray is trading at a lower price-to-earnings ratio than Mind Medicine (MindMed), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTilray$210.48M5.36-$244.98M-$0.27-4.63Mind Medicine (MindMed)N/AN/A-$95.73M-$2.26-3.30 Does the MarketBeat Community favor TLRY or MNMD? Tilray received 397 more outperform votes than Mind Medicine (MindMed) when rated by MarketBeat users. However, 92.59% of users gave Mind Medicine (MindMed) an outperform vote while only 59.21% of users gave Tilray an outperform vote. CompanyUnderperformOutperformTilrayOutperform Votes44759.21% Underperform Votes30840.79% Mind Medicine (MindMed)Outperform Votes5092.59% Underperform Votes47.41% Do analysts rate TLRY or MNMD? Tilray currently has a consensus price target of $2.63, suggesting a potential upside of 110.00%. Mind Medicine (MindMed) has a consensus price target of $27.71, suggesting a potential upside of 271.51%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher probable upside, analysts plainly believe Mind Medicine (MindMed) is more favorable than Tilray.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Mind Medicine (MindMed) 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 3 Strong Buy rating(s) 3.27 Do institutionals & insiders have more ownership in TLRY or MNMD? 9.4% of Tilray shares are owned by institutional investors. Comparatively, 27.9% of Mind Medicine (MindMed) shares are owned by institutional investors. 0.9% of Tilray shares are owned by insiders. Comparatively, 2.3% of Mind Medicine (MindMed) shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer TLRY or MNMD? In the previous week, Tilray had 10 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 15 mentions for Tilray and 5 mentions for Mind Medicine (MindMed). Tilray's average media sentiment score of 0.49 beat Mind Medicine (MindMed)'s score of 0.42 indicating that Tilray is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray 2 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Mind Medicine (MindMed) 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is TLRY or MNMD more profitable? Mind Medicine (MindMed) has a net margin of 0.00% compared to Tilray's net margin of -26.79%. Tilray's return on equity of -2.00% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Tilray-26.79% -2.00% -1.60% Mind Medicine (MindMed) N/A -47.56%-35.55% Which has more volatility & risk, TLRY or MNMD? Tilray has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.58, meaning that its share price is 158% more volatile than the S&P 500. SummaryMind Medicine (MindMed) beats Tilray on 11 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MNMD vs. The Competition Export to ExcelMetricMind Medicine (MindMed)Medicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$547.06M$396.46M$5.14B$9.31BDividend YieldN/AN/A4.81%4.06%P/E Ratio-3.3036.88135.1917.53Price / SalesN/A6.071,224.59140.21Price / CashN/A10.6640.6537.95Price / Book3.931.994.884.92Net Income-$95.73M-$51.46M$118.97M$225.78M7 Day Performance2.05%-0.97%15.53%-1.58%1 Month Performance9.06%-4.25%15.54%6.67%1 Year Performance110.73%-3.71%34.63%22.48% Mind Medicine (MindMed) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MNMDMind Medicine (MindMed)2.1022 of 5 stars$7.22-3.5%$27.71+283.9%+123.3%$529.46MN/A-3.1957Analyst ForecastNews CoverageTLRYTilray2.7747 of 5 stars$1.20+0.8%$2.63+118.8%-39.7%$1.08B$788.94M-4.542,650Analyst RevisionGap DownCRONCronos Group2.2947 of 5 stars$1.94+0.5%$3.00+54.6%+1.0%$741.62M$87.24M-15.19356Short Interest ↓News CoveragePositive NewsUSNAUSANA Health Sciences2.7963 of 5 stars$36.58-0.2%$35.00-4.3%-30.7%$697.22M$921.01M12.951,800CDXCChromaDex4.6512 of 5 stars$6.10-0.3%$8.00+31.1%+334.8%$465.94M$91.67M620.00106Analyst DowngradeBTMDbiote3.2916 of 5 stars$6.60+3.6%$9.11+38.0%+24.5%$358.62M$193.06M24.77194Analyst ForecastNews CoveragePositive NewsGap UpCGCCanopy Growth2.4144 of 5 stars$3.05-1.9%$3.50+14.8%-41.2%$332.27M$220.27M-0.631,029Analyst DowngradeShort Interest ↓News CoverageACBAurora Cannabis0.3153 of 5 stars$4.29-0.5%N/A-6.9%$235.26M$200.35M-5.671,073MDWDMediWound1.8546 of 5 stars$17.13-0.9%$27.50+60.5%+64.0%$184.76M$19.72M-5.9380Positive NewsFTLFFitLife Brands3.1438 of 5 stars$33.50-1.5%$40.00+19.4%+51.2%$154.03M$62.76M20.1220SNYRSynergy CHC Corp. (Uplisting)N/A$5.50+4.4%N/AN/A$47.85MN/A0.0040Positive NewsGap Up Related Companies and Tools Related Companies TLRY Alternatives CRON Alternatives USNA Alternatives CDXC Alternatives BTMD Alternatives CGC Alternatives ACB Alternatives MDWD Alternatives FTLF Alternatives SNYR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MNMD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNMD Stock Alerts